Advances in limb salvage treatment of osteosarcoma

Osteosarcoma is the most common primary malignant bone tumor; its standard treatment includes neoadjuvant chemotherapy combined with surgery. Neoadjuvant chemotherapy has significantly improved the 5-year survival and limb salvage rates in osteosarcoma since the 1870s. The survival rate of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yichun, Han, Lei, He, Zewei, Li, Xiaojuan, Yang, Suping, Yang, Jifei, Zhang, Ya, Li, Dongqi, Yang, Yihao, Yang, Zuozhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739147/
https://www.ncbi.nlm.nih.gov/pubmed/29296558
http://dx.doi.org/10.1016/j.jbo.2017.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739147/
https://www.ncbi.nlm.nih.gov/pubmed/29296558
http://dx.doi.org/10.1016/j.jbo.2017.11.005

Ejemplares similares